Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses.
about
Intravenous immunoglobulin and Alzheimer's disease: what now?Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain.Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature.Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies.The frequency of homozygous deletion of a developmentally regulated Vh gene (Humhv3005) is increased in patients with chronic idiopathic thrombocytopenic purpura.Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases.Increased immune complexes of hypocretin autoantibodies in narcolepsy.Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion.Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.Immunomodulatory action of intravenous immunoglobulin.High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.Normal serum immunoglobulins participate in the selection of peripheral B-cell repertoires.Population dynamics of natural antibodies in normal and autoimmune individuals.Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.Natural autoantibodies and associated B cells in immunity and autoimmunity.The advantage of specific intravenous immunoglobulin (sIVIG) on regular IVIG: experience of the last decade.Can new chemical therapies improve the management of multiple sclerosis in children?Monomeric and dimeric IgG fractions show differential reactivity against pathogen-derived antigens.Self-reactivity in the dimeric intravenous immunoglobulin fraction.Modulation of autoimmune responses by intravenous immunoglobulin (IVIg).The effect of IgM-enriched human Ig and rabbit antithymocyte globulin on the stimulation of mononuclear cells.In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.Global analysis of antibody repertoires. 1. An immunoblot method for the quantitative screening of a large number of reactivities.I. Immunostimulatory Effect of Thalidomide in Normal C57BL/6 Mice is Compatible with Stimulation of a Highly Connected Central Immune SystemII. The Effects of Thalidomide Treatment on Autoimmune-Prone NZB and MRL Mice are Consistent with Stimulation of the Central Immune System
P2860
Q27000371-630E97A3-B946-47E3-8F31-2A04A1F065D6Q30195408-7E8E45C7-3305-4477-AF74-B54F7A67635AQ30354658-FC491766-D660-4306-851A-0DD5A00E0339Q31039951-87ECA3D2-624B-4C89-B164-6CEA46FFE285Q33364381-179ACEF4-271B-49F3-88A1-41C6F1FF3AD9Q33384840-C19B63BF-7238-47A1-96CF-2CD40EE228A9Q33499241-36C95917-82BE-4BFC-8B2C-B639FC16408FQ33596381-E4E604F5-C349-40BD-8B0A-C70D90DAEF12Q33725437-AC631C1F-4385-456B-B921-7734C32351E7Q34124893-4724D7D3-B50C-497A-9846-18E1EC249735Q34244201-6C7A0678-9549-40D3-908C-67088B7EBEEFQ35013334-CC45DA7C-BB89-46E7-8653-C58C9D9818CBQ36215648-4552C84D-475C-4193-90E7-0D622D9D2BD5Q37540740-E223F257-63F4-4773-905D-AD9B448559E7Q37544248-7D2B8F4A-7FA5-4F1D-9318-C6740467174DQ37656095-49F10903-25AF-48FA-AADC-19F2ECC3B2EFQ38062945-4267671D-AAF0-4FE6-B740-21124B06CAF6Q38066414-3E738878-A11E-403C-B5F5-2A2B7C912F6FQ39024427-877A69A8-66A7-48B7-85BB-D2B4F65C0671Q39588670-843E2207-CA40-4CB5-992F-A89F63B3D821Q40073137-5B99EF6E-293C-4A66-A2E0-AE60684F8110Q41589724-5D200666-212F-4E11-8712-CF156BBB13ABQ43922459-8B76778D-FA60-46A7-B5F0-7B52D8D4EB91Q45857166-2F607639-225D-4B4C-BAF0-5A14C20B57DCQ52384155-262599A4-64AF-4AE5-92CE-C6A35A0BB260Q57714714-86C059E1-BAC5-4A37-B56D-34C66AD1E7F6Q57714717-EA0B7C10-ABC2-457C-B671-3D5F3BA3AE09
P2860
Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Anti-idiotypes against autoant ...... of human autoimmune responses.
@en
type
label
Anti-idiotypes against autoant ...... of human autoimmune responses.
@en
prefLabel
Anti-idiotypes against autoant ...... of human autoimmune responses.
@en
P2093
P2860
P1476
Anti-idiotypes against autoant ...... of human autoimmune responses.
@en
P2093
Dietrich G
Kazatchkine MD
P2860
P304
P356
10.1111/J.1600-065X.1989.TB00031.X
P577
1989-08-01T00:00:00Z